Known targets — ChEMBL curated mechanism
CHRM1DRD2DRD3DRD4HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HTR2APDE3ASIGMAR1SLC9A3
The experimentally established mechanism targets of L-Lactic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TP53 | P04637 | 1/20 | 0.47 |
| ▸ | CA1 | P00915 | 4/20 | 0.38 |
| ▸ | CA4 | P22748 | 3/20 | 0.36 |
| ▸ | CA2 | P00918 | 1/20 | 0.36 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.35 |
| ▸ | TSHR | P16473 | 2/20 | 0.35 |
| ▸ | NFKB1 | P19838 | 2/20 | 0.35 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| L-Lactic Acid SCHEMBL29543519 | 1.00 | TP53 (0.47) | TP53CA1CA4CA2CYP3A4 | |
| L-Lactic Acid SCHEMBL109735 | 1.00 | TP53 (0.47) | TP53CA1CA4CA2CYP3A4 | |
| L-Lactic Acid SCHEMBL9770204 | 1.00 | TP53 (0.47) | TP53CA1CA4CA2CYP3A4 | |
| L-Lactic Acid SCHEMBL4737418 | 1.00 | TP53 (0.47) | TP53CA1CA4CA2CYP3A4 | |
| L-Lactic Acid SCHEMBL407161 | 1.00 | TP53 (0.47) | TP53CA1CA4CA2CYP3A4 | |
| L-Lactic Acid SCHEMBL4648043 | 0.96 | TP53 (0.50) | TP53CA1CA4CA2CYP3A4 | |
| L-Lactic Acid SCHEMBL29683322 | 0.96 | TP53 (0.50) | TP53CA1CA4CA2CYP3A4 | |
| L-Lactic Acid SCHEMBL29351424 | 0.96 | TP53 (0.50) | TP53CA1CA4CA2CYP3A4 | |
| L-Lactic Acid SCHEMBL4319 | 0.96 | TP53 (0.50) | TP53CA1CA4CA2CYP3A4 | |
| L-Lactic Acid SCHEMBL1532627 | 0.96 | TP53 (0.50) | TP53CA1CA4CA2CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 931 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122060620-A | Lactobacillus plantarum microbial preparation and preparation method and application thereof | 乐山恒峰华邦生物科技有限公司 | 2026-05-19 | — | — | CN | claimed |
| WO-2026099516-A1 | SMOKELESS ARTICLE | IMPERIAL TOBACCO LIMITED (GB) | 2026-05-15 | — | — | WO | claimed |
| EP-4740756-A1 | SMOKELESS ARTICLE | IMPERIAL TOBACCO LIMITED (GB) | 2026-05-13 | — | — | EP | claimed |
| EP-4687485-A1 | NOVEL COMBINATIONS COMPRISING KONJAC MANNAN, THEIR COMPOSITIONS AND USES THEREOF | Vivatis Pharma GmbH (DE) | 2026-02-11 | — | — | EP | claimed |
| EP-4687486-A1 | NOVEL COMBINATIONS COMPRISING KONJAC MANNAN, THEIR COMPOSITIONS AND USES THEREOF | Vivatis Pharma GmbH (DE) | 2026-02-11 | — | — | EP | claimed |
| EP-4611550-A1 | COCOA-FREE CHOCOLATE | Nukoko Limited (GB) | 2025-09-10 | — | — | EP | claimed |
| WO-2025125392-A1 | IMPROVEMENTS IN OR RELATING TO ORGANIC COMPOUNDS | GIVAUDAN SA (CH) | 2025-06-19 | — | — | WO | claimed |
| CN-120054445-A | CO (carbon monoxide)2Adsorbent and preparation method thereof | 上海第二工业大学 | 2025-05-30 | — | — | CN | claimed |
| WO-2025078588-A1 | METHOD AND SYSTEM FOR PREPARING AGGLOMERATED EXCIPIENT GRANULES | DFE PHARMA GMBH & CO. KG (DE) | 2025-04-17 | — | — | WO | claimed |
| EP-4537831-A2 | PHARMACEUTICAL COMPOSITIONS WITH ANTI-RANKL ANTIBODIES, CALCIUM AND VITAMIN D, SUITABLE FOR THE TREATMENT AND/OR PROPHYLAXIS OF DISORDERS OF THE BONE METABOLISM AND THERAPY-INDUCED SIDE EFFECTS SUCH AS HYPOCALCEMIA | Karl, Christoph (CH) | 2025-04-16 | — | — | EP | claimed |
| US-20040180080-A1 | Fentanyl compound-containing edible patch to be applied to oral mucosa | KYUKYU PHARMACEUTICAL CO., LTD. (JP) | 2004-09-16 | — | — | US | claimed |
| US-6565871-B2 | For administration of a bioactive material to subcutaneous and intradermal tissue | ELAN DRUG DELIVERY LTD. (GB) | 2003-05-20 | — | — | US | claimed |
| US-20020012687-A1 | Solid dose delivery vehicle and methods of making same | QDOSE LIMITED (GB) | 2002-01-31 | — | — | US | claimed |
| CN-1284335-A | Flour and special food containing calcium phosphate | LIU WENSHENG (CN) | 2001-02-21 | — | — | CN | claimed |
| EP-0563455-A1 | Particulate solid products containing a lump forming inhibitor | Purac Biochem B.V. (NL) | 1993-10-06 | — | — | EP | claimed |
| US-5051272-A | Sutures from polymers which are stable for storage | UNITED STATES SURGICAL CORPORATION (US) | 1991-09-24 | — | — | US | claimed |
| EP-0079838-B1 | FLOCCULANT AID AND PROCESS FOR WATER PURIFICATION | RHONE-POULENC CHIMIE (FR) | 1987-05-13 | — | — | EP | claimed |
| EP-0079836-B1 | COMPOSITIONS BASED ON WATER-SOLUBLE GUMS, THEIR PREPARATION AND THEIR USE | RHONE-POULENC CHIMIE (FR) | 1987-01-21 | — | — | EP | claimed |
| US-4565635-A | GUM, POLYMER, OR BIOGUM MATERIAL AND WATER DONOR MATERIAL MIXTURE | RHONE-POULENC SPECIALITES CHIMIQUES (FR) | 1986-01-21 | — | — | US | claimed |
| US-4519844-A | HETEROPOLYSACCHARIDE AND WATER DONOR | RHONE-POULENC SPECIALITES CHIMIQUES (FR) | 1985-05-28 | — | — | US | claimed |